Neumora Therapeutics, Inc. (NASDAQ:NMRA) is one of the 11 Best New Penny Stocks to Buy Right Now. On July 16, Mizuho increased its price target for Neumora Therapeutics, Inc. (NASDAQ:NMRA) from $4 to ...

Neumora Therapeutics, Inc. NMRA announced that the FDA has placed a clinical hold on the phase I study, which evaluated NMRA-266, its positive allosteric modulator (PAM) of the M4 muscarinic receptor, ...

The 2025 National Model Railroad Association convention recently wrapped up with encouraging attendance numbers. A July 19 post from the NMRA social media pages highlighted the success: 950 registered ...

WATERTOWN, Mass., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced ...

Neumora Therapeutics, Inc. has announced the initiation of a Phase 1 study for NMRA-861, a potent and selective positive allosteric modulator of the M4 muscarinic receptor, aimed at treating ...

Neumora Therapeutics (NMRA) shares drew fresh attention after the company announced two advances in its clinical pipeline. The launch of a Phase 1 trial for NMRA-898 and new preclinical results for ...

WATERTOWN, Mass., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company redefining neuroscience drug development, today announced the ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Ladies and gentlemen, thank you for standing by. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to turn the conference over to Helen Rubinstein, ...